Catalyst Wire Dossier Catalyst Wire Dossier

Ritonavir-boosted danoprevir

danoprevir · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ritonavir-boosted danoprevir, covering 2016-08-01 to 2020-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan [Phase 2]

See pricing